Epistem
Epistem is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
An Open-Label, Single Agent, Phase I/II Trial Investigating the Safety and Efficacy of RVU120 (SEL120) in Patients with Relapse / Refractory Metastatic or Advanced Solid Tumors
Sponsor Ryvu Therapeutics S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available2 trial-level findings · Read insights
- The trial involved seven principal investigators across Spain and Poland.
- Following review of Part 1 preliminary efficacy data and the overall development program, the sponsor proceeded only with Part 2 Group E, including the food-effect substudy; the Part 2 efficacy-expansion groups were not initiated.
These findings describe the trial, not the service provider’s performance or responsibility.
A phase 1/2, first-in-human study on ODM-212 in subjects with selected advanced solid tumours
Sponsor Orion Corporation
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Epistem?
The 2026-10-09 snapshot links Epistem to 2 distinct CTIS trials. Recorded services include Genetic testing., Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Epistem?
The most frequently recorded therapeutic areas are Solid Tumor Oncology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Epistem conducted?
The linked trials record locations in 4 countries, including Spain, Finland, France, Poland. These are trial locations, not confirmed office locations or countries where Epistem delivered services.
What can this page tell me about Epistem's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Epistem. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Epistem Limited